Search results
Apr 27, 2023 · Dr. Catherine Shu is the Price Family Associate Professor of Medicine and a board-certified medical oncologist specializing in the treatment of thoracic cancers, with a focus on lung cancer.
Catherine Shu, Author at TechCrunch. Senior Reporter, TechCrunch. Catherine Shu covered startups in Asia and breaking news for TechCrunch. Her reporting has also appeared in the New York...
Feb 29, 2024 · Catherine Shu covered startups in Asia and breaking news for TechCrunch. Her reporting has also appeared in the New York Times, the Taipei Times, Barron’s, the Wall Street Journal and the ...
A physician-researcher in thoracic oncology, Dr. Catherine Shu has a focused interest in improving outcomes for lung cancer patients with resectable disease, specifically on investigating neoadjuvant therapy—treatments given to a patient prior to surgery.
Dr. Catherine Shu is the Price Family Associate Professor of Medicine and a board-certified medical oncologist specializing in the treatment of thoracic cancers, with a focus on lung cancer.
Sep 20, 2022 · At ASCO 2022, Catherine A. Shu, MD, spoke about the CHRYSALIS-2 trial which investigated the use of amivantamab plus lazertinib in patients with EGFR-mutant non–small cell lung cancer following progression on a prior EGFR inhibitor.
Catherine Shu on LinkedIn: Don't ignore Asia tech | TechCrunch | 40 comments. Catherine Shu’s Post. Director of Content and Media, The PR Group. 3mo. Thank you TechCrunch for giving...
